These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11407129)

  • 1. Olanzapine: another psychotropic?
    Davis MP; Dickerson ED
    Am J Hosp Palliat Care; 2001; 18(2):129-32. PubMed ID: 11407129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focus on olanzapine.
    Green B
    Curr Med Res Opin; 1999; 15(2):79-85. PubMed ID: 10494490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of olanzapine and fluoxetine in mood disorders.
    Shelton RC
    Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The change from clozapine to olanzapine--same effect?].
    Pomp E
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):945-6. PubMed ID: 10795501
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.
    Potenza MN; Wasylink S; Epperson CN; McDougle CJ
    Am J Psychiatry; 1998 Sep; 155(9):1299-300. PubMed ID: 9734562
    [No Abstract]   [Full Text] [Related]  

  • 6. [Olanzapine in the treatment of depressive disorders with psychotic symptoms].
    Adli M; Rossius W; Bauer M
    Nervenarzt; 1999 Jan; 70(1):68-71. PubMed ID: 10087520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine: an updated review of its use in the management of schizophrenia.
    Bhana N; Foster RH; Olney R; Plosker GL
    Drugs; 2001; 61(1):111-61. PubMed ID: 11217867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine and serotonin toxicity.
    Isbister GK; Downes F; Whyte IM
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):241-2. PubMed ID: 12667176
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.
    Poyurovsky M; Kurs R; Weizman A
    J Clin Psychiatry; 2003 May; 64(5):611. PubMed ID: 12755669
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of fluoxetine on olanzapine pharmacokinetics.
    Gossen D; de Suray JM; Vandenhende F; Onkelinx C; Gangji D
    AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.
    Melkersson K; Hulting AL
    Psychosomatics; 2002; 43(1):67-70. PubMed ID: 11927762
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperglycemia and ketoacidosis associated with olanzapine].
    Von Hayek D; Hüttl V; Reiss J; Schweiger HD; Füessl HS
    Nervenarzt; 1999 Sep; 70(9):836-7. PubMed ID: 10522253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
    Weimer E; Braus DF; Cavus I; Thome J
    Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder.
    Marazziti D; Pallanti S
    Am J Psychiatry; 1999 Nov; 156(11):1834-5. PubMed ID: 10553756
    [No Abstract]   [Full Text] [Related]  

  • 15. The economic consequences of a drug-drug interaction.
    Shad MU; Marsh C; Preskorn SH
    J Clin Psychopharmacol; 2001 Feb; 21(1):119-20. PubMed ID: 11199940
    [No Abstract]   [Full Text] [Related]  

  • 16. Remission of tardive dyskinesia after changing from flupenthixol to olanzapine.
    Haberfellner EM
    Eur Psychiatry; 2000 Aug; 15(5):338-9. PubMed ID: 10954879
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine and risperidone.
    Love RC; Kelly DL
    Am J Health Syst Pharm; 2003 Mar; 60(5):487-8; author reply 488-9. PubMed ID: 12635459
    [No Abstract]   [Full Text] [Related]  

  • 18. Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.
    Taylor DM; Wright T; Libretto SE;
    J Clin Psychiatry; 2003 May; 64(5):589-97. PubMed ID: 12755664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic outcomes associated with olanzapine for the treatment of psychotic symptoms in a county mental health population.
    Del Paggio D; Finley PR; Cavano JM
    Clin Ther; 2002 May; 24(5):803-17. PubMed ID: 12075948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine: an atypical antipsychotic for schizophrenia.
    Lund BC; Perry PJ
    Expert Opin Pharmacother; 2000 Jan; 1(2):305-23. PubMed ID: 11249551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.